Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zewei Wang
Observed name:
Wang, Zewei
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
ORCID:
0000-0002-8833-3541
Observed ORCID:
0000-0002-8833-3541
OpenAlex ID:
A5018149676
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
2022
·
Yijia Xu
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
108
PDF
Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture
2020
·
Han Zeng
, Quan Zhou
, et al.
·
Journal for ImmunoTherapy of Cancer
·
55
PDF
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer
2021
·
Mengmeng Sun
, Han Zeng
, et al.
·
Cancer Immunology Immunotherapy
·
52
Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
2016
·
Hangcheng Fu
, Yu Zhu
, et al.
·
Annals of Surgical Oncology
·
49
CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
2016
·
Zewei Wang
, Huyang Xie
, et al.
·
Oncotarget
·
46
CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer
2022
·
Kaifeng Jin
, Yanze Yu
, et al.
·
British Journal of Cancer
·
44
Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
2017
·
Yidong Liu
, Zheng Liu
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
27
Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma
2016
·
Tian Niu
, Yidong Liu
, et al.
·
Oncotarget
·
22
PDF
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin + cell abundance
2020
·
Quan Zhou
, Zewei Wang
, et al.
·
OncoImmunology
·
20
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
2022
·
Zhaopei Liu
, Han Zeng
, et al.
·
British Journal of Cancer
·
19
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
2022
·
Sen Yan
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma
2016
·
Zewei Wang
, Le Xu
, et al.
·
Tumor Biology
·
17
TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1 / PD‐L1 blockade response in urothelial carcinoma
2024
·
Kaifeng Jin
, Jingtong Xu
, et al.
·
The Journal of Pathology
·
16
High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma
2016
·
Zhiying Xu
, Yidong Liu
, et al.
·
Oncotarget
·
15
PDF
Tumor-infiltrating IL-17A + cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
2020
·
Zewei Wang
, Quan Zhou
, et al.
·
OncoImmunology
·
14
PDF
Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
2017
·
Zheng Liu
, Yu Zhu
, et al.
·
Oncotarget
·
14
PDF
High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients
2016
·
Hangcheng Fu
, Yu Zhu
, et al.
·
Oncotarget
·
14
PDF
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
2022
·
Yanze Yu
, Han Zeng
, et al.
·
Cancer Immunology Immunotherapy
·
9
High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma
2016
·
Jieti Wang
, Yidong Liu
, et al.
·
Oncotarget
·
9
PDF
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
2025
·
Kaifeng Jin
, Yawei Ding
, et al.
·
Journal for ImmunoTherapy of Cancer
·
7
PDF
Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients
2022
·
Shengming Jin
, Han Zeng
, et al.
·
Annals of Surgical Oncology
·
7
Gender disparities in clinical outcomes of urothelial carcinoma linked to X chromosome gene KDM6A mutation
2023
·
Zhaopei Liu
, Kaifeng Jin
, et al.
·
BMJ Oncology
·
5
TERT promoter mutations or protein overexpression define an aggressive subset with favourable immunotherapeutic response in advanced urothelial carcinoma
2025
·
Kaifeng Jin
, Jingtong Xu
, et al.
·
BMJ Oncology
·
4
PDF
Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients
2022
·
Chunnan Liu
, Zhaopei Liu
, et al.
·
British Journal of Cancer
·
4
PDF
Integration of CD4+ T cells and molecular subtype predicts benefit from PD‐L1 blockade in muscle‐invasive bladder cancer
2024
·
Ge Liu
, Kaifeng Jin
, et al.
·
Cancer Science
·
3
Show more works
View as search
Works count:
45
Citation count:
607
H-index:
14
I10-index:
17
Year
Topic
Type